Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer
Public ClinicalTrials.gov record NCT00411528. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Multicenter Phase II Trial of Patupilone (EPO906) Plus Prednisone Versus Docetaxel Plus Prednisone in Patients With Metastatic Hormone Refractory Prostate Cancer
Study identification
- NCT ID
- NCT00411528
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 185 participants
Conditions and interventions
Interventions
- Patupilone Drug
- prednisone Drug
- docetaxel Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2006
- Primary completion
- Aug 31, 2012
- Completion
- Aug 31, 2012
- Last update posted
- Dec 16, 2020
2006 – 2012
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California San Diego Dept of Moores Cancer Center | La Jolla | California | 92093-0658 | — |
| University of Colorado Dept. of Univ. of Colorado | Aurora | Colorado | 80045 | — |
| Norwalk Hospital | Norwalk | Connecticut | 06856 | — |
| Georgetown University/Lombardi Cancer Center Dept.of Lombardi Cancer Center | Washington D.C. | District of Columbia | 20007-2197 | — |
| MD Anderson Cancer Center - Orlando CEPO906A2229 | Orlando | Florida | 32806 | — |
| H. Lee Moffitt Cancer Center/University of South Florida Department of Genitourology | Tampa | Florida | 33612 | — |
| Palm Beach Cancer Institute | West Palm Beach | Florida | 33401 | — |
| NorthWest Georgia Oncology Centers Marietta Center | Marietta | Georgia | 30060 | — |
| University Chicago Hospital StudyCoordinator:CEPO906A2229 | Chicago | Illinois | 60637 | — |
| Queens Cancer Center of Queens Hospital | Jamaica | New York | 11432 | — |
| Oregon Health & Science University StudyCoordinator:CEPO906A2229 | Portland | Oregon | 97239 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00411528, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 16, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00411528 live on ClinicalTrials.gov.